
MacroGenics Inc
MGNXNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$4.14
Day High
$4.28
Day Low
$4.13
Prev. Close
$4.21
VolumeShares traded today.
586.93K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$264.42M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-3.74
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$4.64
52W LowLowest price over the past 52 weeks.
$1.19
50D MAAverage closing price over the last 50 trading days.
$3.43
200D MAAverage closing price over the last 200 trading days.
$2.16
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-1.9%1M
+41.5%6M
+186.9%YTD
+158.4%1Y
+199.3%About
Teplizumab, sold under the brand name Tzield among others, is an anti-CD3 humanized monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 type 1 diabetes.
www.macrogenics.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade MGNX
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.